RNA Leaders Podcast Series
WITH
Jacob Sten Petersen,
SVP Nucleic Acid Therapeutics,
Novo Nordisk

Join RNA Leaders's Jade Osei-Tutu continuing the RNA Leaders podcast series as she welcomes Jacob Sten Petersen, SVP Nucleic Acid Therapeutics, Novo Nordisk.  Jacob gives an insight into his leadership roles within pharma, including directing multiple modality platforms to target cardio, oncology diseases.

Jacob goes on to share Novo Nordisk’s approach to siRNA and gene therapy, highlighting the move to look deeper into siRNAs from rare diseases to common diseases. Hear his thoughts on critical steps to progress this approach such as addressing the cost of goods, reagent usage, and targeting organs other than the liver.

Tune in to discover the future of RNA therapeutics and how Novo Nordisk will be engaging with our community at the RNA Leaders USA conference this September.